ADCYAP1 and Parkinson disease: The lowest level of PACAP in the akinetic-rigid group is in accordance with previous findings where PACAP treatment could improve the hypokinetic symptoms induced by unilateral 6-OHDA lesion of substantia nigra in a rat model of PD.